Technology News and Research

RSS

UMB enters license agreement with Bali BioSciences for new strategy to combat sepsis, HIV/AIDS

The University of Maryland, Baltimore's (UMB) Office of Technology Transfer has completed a license agreement with Bali BioSciences LLC, an early-stage company pursuing an unusual, yet clever, strategy to combat disease.

20 Jan 2011

University of Minnesota grants Cellectis rights related to TAL effector-mediated DNA recognition and cleavage

Cellectis, the French genome engineering specialist, has announced today that it has signed an exclusive license agreement with the University of Minnesota that grants Cellectis the worldwide right to use inventions related to TAL effector-mediated DNA recognition and cleavage. This revolutionary approach for the targeted modification of genomes was developed by the University of Minnesota and Iowa State University.

20 Jan 2011

TKA patients undergoing telerehabilitation experience similar results as traditional one: Study

Knee replacement patients undergoing telerehabilitation – a unique Internet-based postoperative rehabilitation program that can be conducted from the patient's home – experience the same results as patients who undergo traditional postoperative rehabilitation, according to a new study published in the Journal of Bone and Joint Surgery.

20 Jan 2011

Endothelial cells may play a role in controlling cancer behavior: New study

MIT scientists have discovered that cells lining the blood vessels secrete molecules that suppress tumor growth and keep cancer cells from invading other tissues, a finding that could lead to a new way to treat cancer.

20 Jan 2011

SCAI publishes guiding principles for development of radiation safety programs in cardiac catheterization laboratories

Today the Society for Cardiovascular Angiography and Interventions published guiding principles and best practices for the development of radiation safety programs in cardiac catheterization laboratories.

20 Jan 2011

Scarab Genomics, WIST enter research agreement to produce isoprene from paper, pulp mill waste streams

Scarab Genomics, a leader in the development of production E. coli strains based on reduced genome technology and the Wisconsin Institute for Sustainable Technology at the University of Wisconsin-Stevens Point have entered into a research agreement to produce isoprene from paper and pulp mill waste streams.

20 Jan 2011

Exciton, ULURU sign agreement to develop and market Altrazeal exSALT product

ULURU Inc. announced today that it has signed a Binding Letter of Intent with Exciton Technologies Inc. to develop and market a product that will combine Altrazeal® with Exciton's proprietary exSALT™ Antimicrobial Technology.

20 Jan 2011

Apricus Bio's MycoVa demonstrates 'non-inferiority' for treatment of onychomycosis compared to Loceryl

Apricus Biosciences, Inc. today announced that an additional analysis conducted on behalf of the Company has shown that MycoVa™ has successfully demonstrated 'non-inferiority' for the treatment of onychomycosis (commonly referred to as nail fungus), compared to the current standard of care in Europe for topical therapy, Loceryl®.

20 Jan 2011

Viewpoints: Sebelius and Vilsack on rural health; Many thoughts on repeal vote; State budget cuts

As former governors from the Heartland, we've seen firsthand how Americans in rural areas struggle to get the health care they need. Whether it's a farmer losing his health insurance because he has no good choices or a mom putting off a treatment because there aren't enough doctors nearby, rural Americans often go without critical preventive care or key procedures.

20 Jan 2011

Dried blood spot technology finds new role in developing lifesaving medications

The blood test procedure used on newborn infants for 40 years is finding a second life in the search for new lifesaving medications, according to an article in the current edition of Chemical & Engineering News, ACS' weekly newsmagazine.

20 Jan 2011

Biomarin commences BMN 701 Phase 1/2 trial for treatment of Pompe disease

BioMarin Pharmaceutical Inc. announced today that it has initiated a Phase 1/2 trial for BMN 701, a novel fusion protein of insulin-like growth factor 2 and acid alpha glucosidase in development for the treatment of Pompe disease.

20 Jan 2011

Scientists determine protein structure that delivers genetic material of HIV to human cells

A team of scientists at The Scripps Research Institute and the University of Virginia has determined the structure of the protein package that delivers the genetic material of the human immunodeficiency virus to human cells.

19 Jan 2011

Boston Scientific announces merger agreement to acquire Atritech

Boston Scientific Corporation today announced the signing of a definitive merger agreement, under which the Company will acquire Atritech, a privately held company based in Plymouth, Minnesota.

19 Jan 2011

Malaria parasite caught in action on film for the first time

Australian researchers have managed to take pictures of microscopic malaria parasite as it invades a human red blood cell. This will provide a deeper understanding of the parasite’s behaviour and may help fight it. Up to 10% of the world’s population contract malaria every year and a million people, mostly pregnant women and children, die as a result of the parasite transmitted by infected mosquitoes.

19 Jan 2011

USPTO grants KL4 surfactant combination product patent to Discovery Labs

Discovery Laboratories, Inc. has been notified that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent Number 7,863,241 titled "Compositions for Treatment and Prevention of Pulmonary Conditions." The patent provides broad coverage for compositions that employ a combination of certain pulmonary surfactants with a broad array of protease inhibitors, administered as either a liquid or aerosol, for treating pulmonary inflammation.

19 Jan 2011

Home blood pressure monitors can help people keep blood pressure in check

A recent research review has concluded that home blood pressure monitors can help people keep their blood pressure in check and possibly cut down on medication – as long as patients and their doctors put those home readings to good use. For years, Omron Healthcare, Inc. has reminded Americans how important home blood pressure monitoring is when it comes to reducing their risk of a heart attack or stroke, and truly wants people to take the news to heart in 2011.

19 Jan 2011

Theraclone, Pfizer enter multi-year research and development collaboration

Theraclone Sciences, Inc., a therapeutic antibody discovery and development company, announced today that they have entered into a multi-year research and development collaboration with Pfizer. The collaboration will use Theraclone's I-STAR™ technology to discover broadly protective monoclonal antibodies against up to four undisclosed targets in the areas of infectious disease and cancer.

19 Jan 2011

Pisgah to scale-up patent-pending form of hydrocodone

As Pisgah Laboratories, Inc. continues development of its lead abuse deterrent opioid product, it will soon begin scale-up of its patent-pending form of hydrocodone. Pisgah has developed a specialized salt form of hydrocodone which imparts abuse deterrent properties to a dosage product. Pisgah will manufacture its hydrocodone salt for clinical trials in their FDA / DEA registered facility.

19 Jan 2011

Medtech forms new 10-school company

Medtech today announced the formation of a new 10-school company that is positioned to become a leading post-secondary healthcare career education provider. The schools include four current Midwestern campuses, along with three Sanz Schools in the Washington, D.C. area and three Javelin Technical Training Centers in greater Atlanta that will adopt the Medtech name.

19 Jan 2011

Linguamatics releases new 'cloud' version of I2E text mining platform

Linguamatics, a leading provider of NLP (Natural Language Processing) based text mining software, today announced the launch of its new "cloud" (online) version of the award winning I2E text mining platform. I2E OnDemand offers smaller companies the advanced, high performance text mining capabilities that big pharma companies have been using for years.

19 Jan 2011

Technology News and Research

UMB enters license agreement with Bali BioSciences for new strategy to combat sepsis, HIV/AIDS

University of Minnesota grants Cellectis rights related to TAL effector-mediated DNA recognition and cleavage

TKA patients undergoing telerehabilitation experience similar results as traditional one: Study

Endothelial cells may play a role in controlling cancer behavior: New study

SCAI publishes guiding principles for development of radiation safety programs in cardiac catheterization laboratories

Scarab Genomics, WIST enter research agreement to produce isoprene from paper, pulp mill waste streams

Exciton, ULURU sign agreement to develop and market Altrazeal exSALT product

Apricus Bio's MycoVa demonstrates 'non-inferiority' for treatment of onychomycosis compared to Loceryl

Viewpoints: Sebelius and Vilsack on rural health; Many thoughts on repeal vote; State budget cuts

Dried blood spot technology finds new role in developing lifesaving medications

Biomarin commences BMN 701 Phase 1/2 trial for treatment of Pompe disease

Scientists determine protein structure that delivers genetic material of HIV to human cells

Boston Scientific announces merger agreement to acquire Atritech

Malaria parasite caught in action on film for the first time

USPTO grants KL4 surfactant combination product patent to Discovery Labs

Home blood pressure monitors can help people keep blood pressure in check

Theraclone, Pfizer enter multi-year research and development collaboration

Pisgah to scale-up patent-pending form of hydrocodone

Medtech forms new 10-school company

Linguamatics releases new 'cloud' version of I2E text mining platform

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News